A Phase I Study of Adjuvant Chemotherapy With GC in Biliary Tract Cancer Undergoing Resection Without Major Hepatectomy
Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
To decide maximum tolerated dose and recommended dose of treatment using gemcitabine plus
cisplatin combination therapy in patients with biliary tract cancer undergoing resection
without major hepatectomy.